Tag: Gravis

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Gravis

Precision Therapeutics: Charting the Future Trajectory of the China Myasthenia Gravis ...

Added to Collection on: 2023-12-02 05:12:53

Tags for this article:

Autoimmune diseases
Myasthenia gravis
Myasthenia
Gravis
Weakness
Neuromuscular junction disease
Epigenetics of neurodegenerative diseases

Click the tags to see associated articles and topics

View Article Details
ACNR

Added to Collection on: 2024-04-02 14:02:01

Tags for this article:

Neurosurgical procedures
Cerebellum
Electrotherapy
Medical devices
Neurotechnology
Myasthenia gravis
Gravis
Myasthenia
Deep brain stimulation

Click the tags to see associated articles and topics

View Article Details
Generalized Myasthenia Gravis Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical ...

Added to Collection on: 2024-05-08 18:43:07

Tags for this article:

Orphan drugs
Autoimmune diseases
GMG
Myasthenia gravis
Rozanolixizumab
Gravis
Myasthenia
Ptosis
Celgene Corporation
Janssen Research & Development LLC
Vertex Pharmaceuticals Incorporated
Alexion Pharmaceuticals
argenx
UCB Pharma
HOFFMANN - LA ROCHE

Click the tags to see associated articles and topics

View Article Details
Clinical features of COVID-19 infection in patients with myasthenia gravis - Frontiers

Added to Collection on: 2024-08-13 19:49:54

Tags for this article:

North China Plain
Tianjin
Gravis

Click the tags to see associated articles and topics

View Article Details
Johnson & Johnson Submits Biologics License Application for Nipocalimab in Patients with ...

Added to Collection on: 2024-08-30 23:34:08

Tags for this article:

Autoimmune diseases
Myasthenia gravis
Gravis
MuSK protein
GMG
Eye diseases
, Johnson &Johnson
Johnson & Johnson

Click the tags to see associated articles and topics

View Article Details
FDA approves Soliris for patients aged 6 years and up with generalized myasthenia gravis

Added to Collection on: 2025-03-12 17:56:11

Tags for this article:

Autoimmune diseases
Monoclonal antibodies
Orphan drugs
Eculizumab
Immunosuppressants
Myasthenia gravis
Gravis
Email
Atypical hemolytic uremic syndrome
Neuromuscular junction
Acetylcholine receptor

Click the tags to see associated articles and topics

View Article Details
FDA Approves Imaavy for Long Term Treatment of Generalized Myasthenia Gravis

Added to Collection on: 2025-05-01 21:07:04

Tags for this article:

Autoimmune diseases
Monoclonal antibodies
Myasthenia gravis
Nipocalimab
Autoantibody
Neonatal fragment crystallizable receptor
Acetylcholine receptor
Acetylcholine
Gravis
GMG
Congenital myasthenic syndrome
Neuromuscular junction disease
United States

Click the tags to see associated articles and topics

View Article Details
Johnson & Johnson's IMAAVY Gets FDA Approval, Taking on Top Players in Myasthenia ...

Added to Collection on: 2025-05-22 21:50:43

Tags for this article:

Orphan drugs
Monoclonal antibodies
Nipocalimab
Myasthenia gravis
Eculizumab
GMG
Efgartigimod alfa/hyaluronidase
Efgartigimod alfa
Gravis
Neonatal fragment crystallizable receptor
Batoclimab
Rozanolixizumab
Japan
United States

Click the tags to see associated articles and topics

View Article Details
J&J's Nipocalimab Advances in gMG Treatment: Strategic Positioning in the Neuromuscular ...

Added to Collection on: 2025-09-19 17:43:56

Tags for this article:

Orphan drugs
Monoclonal antibodies
Autoimmune diseases
Nipocalimab
Myasthenia gravis
Neonatal fragment crystallizable receptor
GMG
Eculizumab
Gravis
Efgartigimod alfa
Food and Drug Administration
Johnson & Johnson
Johnson & Johnson's

Click the tags to see associated articles and topics

View Article Details
Myasthenia Gravis Market Outlook 2034 – Clinical Trials, Market Size, Medication ...

Added to Collection on: 2025-09-29 17:07:35

Tags for this article:

Orphan drugs
Monoclonal antibodies
Autoimmune diseases
Myasthenia gravis
Acetylcholinesterase inhibitors
Quaternary ammonium compounds
Nipocalimab
Thymectomy
Gravis
Efgartigimod alfa
MuSK protein
Pyridostigmine
Germany
Efgartigimod IV
Italy
Takeda
Kyverna Therapeutics
Dianthus Therapeutics
France
Japan
United States
United Kingdom
cartesian therapeutics
COUR Pharmaceuticals
AstraZeneca
HOFFMANN - LA ROCHE
Spain
Regeneron Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Book a Demo